Schroeder Thilo's Form 4 filing
Revolution Medicines, Inc. (RVMD) · filed Mar 10, 2023
- Accession no.
- 0001209191-23-017977
- Filed
- Mar 10, 2023
- Trade date
- Mar 7-10, 2023
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $14.1M. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2023 | Common Stock | PPurchaseAcquired | +231,819 | $22.00 | +$5,100,018 | 1,453,134 | Indirect | |
| Mar 7, 2023 | Common Stock | PPurchaseAcquired | +318,181 | $22.00 | +$6,999,982 | 618,181 | Indirect | |
| Mar 10, 2023 | Common Stock | PPurchaseAcquired | +93,800 | $20.43 | +$1,916,334 | 1,546,934 | Indirect | |
| Mar 10, 2023 | Common Stock | PPurchaseAcquired | +6,200 | $20.85 | +$129,270 | 1,553,134 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.